We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Highlights: Phase I trial agreement with leading clinical research organization Human safety and tolerability study to assess infusion of RECCE® 327 in 40 healthy subjects as a single ascending...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.045 | -9 | 0.5 | 0.5 | 0.435 | 102302 | 0.4648746 | DE |
4 | -0.015 | -3.1914893617 | 0.47 | 0.55 | 0.43 | 181907 | 0.47595471 | DE |
12 | -0.075 | -14.1509433962 | 0.53 | 0.57 | 0.38 | 187291 | 0.48768157 | DE |
26 | -0.125 | -21.5517241379 | 0.58 | 0.62 | 0.38 | 193487 | 0.48602947 | DE |
52 | -0.065 | -12.5 | 0.52 | 0.695 | 0.38 | 158874 | 0.49374075 | DE |
156 | -0.515 | -53.0927835052 | 0.97 | 1.38 | 0.38 | 145341 | 0.62358614 | DE |
260 | 0.125 | 37.8787878788 | 0.33 | 1.875 | 0.21 | 244457 | 0.79223054 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions